Implication of folate deficiency in CYP2U1 loss of function
- PMID: 34546337
- PMCID: PMC8480666
- DOI: 10.1084/jem.20210846
Implication of folate deficiency in CYP2U1 loss of function
Abstract
Hereditary spastic paraplegias are heterogeneous neurodegenerative disorders. Understanding of their pathogenic mechanisms remains sparse, and therapeutic options are lacking. We characterized a mouse model lacking the Cyp2u1 gene, loss of which is known to be involved in a complex form of these diseases in humans. We showed that this model partially recapitulated the clinical and biochemical phenotypes of patients. Using electron microscopy, lipidomic, and proteomic studies, we identified vitamin B2 as a substrate of the CYP2U1 enzyme, as well as coenzyme Q, neopterin, and IFN-α levels as putative biomarkers in mice and fluids obtained from the largest series of CYP2U1-mutated patients reported so far. We also confirmed brain calcifications as a potential biomarker in patients. Our results suggest that CYP2U1 deficiency disrupts mitochondrial function and impacts proper neurodevelopment, which could be prevented by folate supplementation in our mouse model, followed by a neurodegenerative process altering multiple neuronal and extraneuronal tissues.
© 2021 Pujol et al.
Conflict of interest statement
Disclosures: F. Darios reports "other" from Dynacure SAS outside the submitted work. D. Galatolo is supported by a grant from Treat SPG56. G. Stevanin reports grants from ASL-HSP association, the Tom-Wahlig-Stiftung Foundation, and the European Union 7th Framework Programme (Neuromics); non-financial support from Agence Nationale de la Recherche (framework programme Investissements d'Avenir) during the conduct of the study; and grants from Biogen outside the submitted work. N. Vilain reports grants from Fondation Bettencourt-Schueller, Fondation Servier, Union Nationale pour les Intérêts de la Médecine, and Fondation pour la Recherche sur l'Alzheimer; non-financial support from Movement Disorders Society, Merz-Pharma, and GE Healthcare SAS; and "other" from Biogen, Eisai, Eli-Lilly, Roche, Janssen - Johnson & Johnson, and Alector outside the submitted work. No other disclosures were reported.
Figures






Similar articles
-
CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56.Hum Mutat. 2018 Jan;39(1):140-151. doi: 10.1002/humu.23359. Epub 2017 Nov 11. Hum Mutat. 2018. PMID: 29034544
-
Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B4.Int J Mol Sci. 2022 Nov 23;23(23):14615. doi: 10.3390/ijms232314615. Int J Mol Sci. 2022. PMID: 36498943 Free PMC article.
-
Pseudoxanthoma elasticum overlaps hereditary spastic paraplegia type 56.J Intern Med. 2021 May;289(5):709-725. doi: 10.1111/joim.13193. Epub 2021 Mar 31. J Intern Med. 2021. PMID: 33107650
-
Cytochrome P450 2U1, a very peculiar member of the human P450s family.Cell Mol Life Sci. 2017 May;74(10):1859-1869. doi: 10.1007/s00018-016-2443-3. Epub 2017 Jan 12. Cell Mol Life Sci. 2017. PMID: 28083596 Free PMC article. Review.
-
Update and new concepts in vitamin responsive disorders of folate transport and metabolism.J Inherit Metab Dis. 2012 Jul;35(4):665-70. doi: 10.1007/s10545-011-9418-1. Epub 2011 Nov 23. J Inherit Metab Dis. 2012. PMID: 22108709 Review.
Cited by
-
Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals.Front Endocrinol (Lausanne). 2023 Jan 4;13:1034494. doi: 10.3389/fendo.2022.1034494. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686439 Free PMC article.
-
iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.J Clin Invest. 2023 May 1;133(9):e163771. doi: 10.1172/JCI163771. J Clin Invest. 2023. PMID: 37115691 Free PMC article.
-
Pluripotent Stem Cells as a Preclinical Cellular Model for Studying Hereditary Spastic Paraplegias.Int J Mol Sci. 2024 Feb 23;25(5):2615. doi: 10.3390/ijms25052615. Int J Mol Sci. 2024. PMID: 38473862 Free PMC article. Review.
-
CYP2U1: An emerging treatable neurometabolic disease with cerebral folate deficiency in 2 Chinese brothers.Mol Genet Metab Rep. 2023 Nov 21;38:101023. doi: 10.1016/j.ymgmr.2023.101023. eCollection 2024 Mar. Mol Genet Metab Rep. 2023. PMID: 38058766 Free PMC article.
-
Assessing cytochrome P450 function using genetically engineered mouse models.Adv Pharmacol. 2022;95:253-284. doi: 10.1016/bs.apha.2022.05.008. Epub 2022 Jun 30. Adv Pharmacol. 2022. PMID: 35953157 Free PMC article. Review.
References
-
- Bibi, F., Efthymiou S., Bourinaris T., Tariq A., Zafar F., Rana N., Salpietro V., Houlden H., Raja G.K., Saeed S., and Minhas N.M.. SYNaPS Study Group . 2020. Rare novel CYP2U1 and ZFYVE26 variants identified in two Pakistani families with spastic paraplegia. J. Neurol. Sci. 411:116669. 10.1016/j.jns.2020.116669 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases